modern Inc. said it is developing two potential COVID-19 booster shots targeting different Omicron subvariants, citing differences in market preferences between the US and other countries.
The Cambridge, Mass., company said on Monday it has met regulatory authority requests for one of its new booster shots in the European Union, UK and Australia. The company expects to complete regulatory filings elsewhere this week.